Stock listing
NASDAQ:COAG Hemab Therapeutics Holdings, Inc. Stock
Home listing (NASDAQ) of Hemab Therapeutics Holdings, Inc.
Follow Hemab Therapeutics Holdings, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:COAG
$45.09 USD +1.99 (+4.6%)
Close on Nov 4, 2026
- Day range
- $41.96 – $45.14 USDNov 4, 2026
- Volume
- 499,700 sharesNov 4, 2026
- Market cap
- $2.11B USDAt the close on Nov 4, 2026 · price × 46.71M shares outstanding
- Traded on an average day
- $18.24M USDMedian day 378,605 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:COAG · Home | $45.09 USD | +1.99 (+4.6%) | 499,700 | $45.00 | $45.14 | $41.96 | $43.10 | Close on Nov 4, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:COAG · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $45.09 | +1.99 | +4.6% | $45.00 | $45.14 | $41.96 | 499,700 | |
| $43.10 | +1.92 | +4.7% | $41.90 | $44.36 | $41.15 | 465,768 | |
| $41.18 | -0.27 | -0.7% | $41.67 | $42.91 | $39.96 | 343,874 | |
| $41.45 | +1.03 | +2.5% | $40.34 | $42.85 | $39.38 | 765,549 | |
| $40.42 | +1.92 | +5.0% | $38.89 | $42.23 | $38.75 | 1,195,908 | |
| $38.50 | +0.10 | +0.3% | $38.23 | $38.78 | $37.26 | 414,023 | |
| $38.40 | +2.38 | +6.6% | $36.35 | $38.58 | $35.64 | 380,009 | |
| $36.02 | +1.62 | +4.7% | $34.73 | $36.39 | $34.39 | 269,190 | |
| $34.40 | -0.415 | -1.2% | $34.58 | $36.70 | $33.89 | 271,177 | |
| $34.82 | -0.525 | -1.5% | $35.20 | $35.90 | $34.44 | 368,983 | |
| $35.34 | +1.17 | +3.4% | $34.17 | $36.33 | $34.13 | 388,273 | |
| $34.17 | +2.08 | +6.5% | $32.16 | $34.53 | $31.32 | 397,751 | |
| $32.09 | +2.02 | +6.7% | $30.12 | $32.37 | $29.88 | 254,486 | |
| $30.07 | -2.45 | -7.5% | $32.56 | $32.56 | $29.87 | 351,800 | |
| $32.52 | +2.58 | +8.6% | $30.20 | $33.50 | $30.20 | 478,300 | |
| $29.94 | +0.14 | +0.5% | $29.75 | $30.42 | $29.01 | 224,900 | |
| $29.80 | -0.59 | -1.9% | $30.59 | $31.05 | $29.11 | 442,000 | |
| $30.39 | -1.23 | -3.9% | $31.68 | $32.15 | $30.20 | 235,000 | |
| $31.62 | +0.73 | +2.4% | $30.65 | $33.93 | $29.98 | 619,100 | |
| $30.89 | +2.19 | +7.6% | $28.60 | $31.31 | $27.39 | 616,400 | |
| $28.70 | +0.33 | +1.2% | $28.25 | $28.98 | $27.38 | 377,200 | |
| $28.37 | -2.22 | -7.3% | $30.81 | $30.89 | $28.01 | 436,800 | |
| $30.59 | -0.52 | -1.7% | $31.11 | $31.11 | $29.76 | 294,500 | |
| $31.11 | +0.05 | +0.2% | $31.49 | $31.49 | $30.06 | 354,100 | |
| $31.06 | +0.22 | +0.7% | $30.82 | $31.35 | $29.63 | 437,800 | |
| $30.84 | -1.76 | -5.4% | $32.92 | $33.27 | $30.80 | 865,200 | |
| $32.60 | -0.52 | -1.6% | $32.99 | $33.95 | $31.80 | 452,000 | |
| $33.12 | -1.62 | -4.7% | $34.39 | $34.41 | $32.60 | 348,500 | |
| $34.74 | -0.98 | -2.7% | $35.70 | $36.10 | $34.74 | 266,500 | |
| $35.72 | -1.01 | -2.7% | $36.89 | $37.64 | $34.01 | 401,300 | |
| $36.73 | -1.52 | -4.0% | $38.38 | $38.98 | $34.99 | 417,100 | |
| $38.25 | +0.28 | +0.7% | $38.53 | $39.81 | $37.42 | 550,100 | |
| $37.97 | -3.22 | -7.8% | $41.20 | $43.21 | $37.54 | 556,800 | |
| $41.19 | -0.03 | -0.1% | $41.67 | $42.31 | $40.85 | 4,149,500 | |
| $41.22 | +0.25 | +0.6% | $41.23 | $43.47 | $40.42 | 429,000 | |
| $40.97 | +0.86 | +2.1% | $40.44 | $43.98 | $39.97 | 597,200 | |
| $40.11 | -0.36 | -0.9% | $40.15 | $40.65 | $39.29 | 256,900 | |
| $40.47 | +1.07 | +2.7% | $39.40 | $40.88 | $38.79 | 459,500 | |
| $39.40 | -0.48 | -1.2% | $40.26 | $42.48 | $38.98 | 408,100 | |
| $39.88 | -4.62 | -10.4% | $44.32 | $44.52 | $39.50 | 433,600 | |
| $44.50 | -0.07 | -0.2% | $44.77 | $46.20 | $43.05 | 429,300 | |
| $44.57 | +0.16 | +0.4% | $44.03 | $45.49 | $43.10 | 358,000 | |
| $44.41 | +0.04 | +0.1% | $43.40 | $45.49 | $43.29 | 302,000 | |
| $44.37 | -0.33 | -0.7% | $44.62 | $45.28 | $43.02 | 257,200 | |
| $44.70 | +0.68 | +1.5% | $44.51 | $46.83 | $42.71 | 325,200 | |
| $44.02 | -1.71 | -3.7% | $45.81 | $47.00 | $43.34 | 318,500 | |
| $45.73 | +0.89 | +2.0% | $44.66 | $46.43 | $43.08 | 591,600 | |
| $44.84 | -4.65 | -9.4% | $48.84 | $49.37 | $44.64 | 260,100 | |
| $49.49 | +0.30 | +0.6% | $49.15 | $51.11 | $48.61 | 355,000 | |
| $49.19 | -0.46 | -0.9% | $49.77 | $52.00 | $47.97 | 334,200 | |
| $49.65 | +2.98 | +6.4% | $46.67 | $50.36 | $46.58 | 527,159 | |
| $46.67 | -2.49 | -5.1% | $49.10 | $50.15 | $46.46 | 336,958 | |
| $49.16 | +0.96 | +2.0% | $48.85 | $53.00 | $46.99 | 391,800 | |
| $48.20 | -3.46 | -6.7% | $50.76 | $51.69 | $46.57 | 426,500 | |
| $51.66 | -0.78 | -1.5% | $53.42 | $54.05 | $50.85 | 279,900 | |
| $52.44 | -1.15 | -2.1% | $53.00 | $55.37 | $52.30 | 183,100 | |
| $53.59 | -1.35 | -2.5% | $54.78 | $55.18 | $51.77 | 208,900 | |
| $54.94 | +0.99 | +1.8% | $53.76 | $55.42 | $50.59 | 101,200 | |
| $53.95 | +0.47 | +0.9% | $54.74 | $55.18 | $52.00 | 171,400 | |
| $53.48 | +1.74 | +3.4% | $52.12 | $54.66 | $50.85 | 278,100 | |
| $51.74 | +1.87 | +3.7% | $49.87 | $52.27 | $49.62 | 251,600 | |
| $49.87 | +0.21 | +0.4% | $49.66 | $51.81 | $48.76 | 299,100 | |
| $49.66 | -2.50 | -4.8% | $52.51 | $53.33 | $48.62 | 415,700 | |
| $52.16 | +2.07 | +4.1% | $50.20 | $53.61 | $49.80 | 278,800 | |
| $50.09 | +3.57 | +7.7% | $46.77 | $50.16 | $46.29 | 353,400 | |
| $46.52 | +1.52 | +3.4% | $45.23 | $49.48 | $45.23 | 484,700 |
- Ticker
- NASDAQ:COAG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition
Nov 4, 2026
Closed $45.09 (+4.6%) on Nov 4, 2026
Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026
Nov 3, 2026
Closed $43.10 (+4.7%) on Nov 3, 2026
Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert
Sep 24, 2026
Closed $34.74 (-2.7%) on Sep 25, 2026
Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding
Sep 17, 2026
Closed $41.22 (+0.6%) on Sep 17, 2026
Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 11, 2026
Closed $51.74 (+3.7%) on Aug 11, 2026
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
Jul 14, 2026
Closed $43.31 (+9.6%) on Jul 14, 2026
Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress
Jul 12, 2026
Closed $39.51 (+3.9%) on Jul 13, 2026
Hemab Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Closed $28.60 (+2.7%) on May 27, 2026
Hemab Therapeutics Reports First Quarter 2026 Financial Results
May 21, 2026
Closed $26.30 (-0.6%) on May 21, 2026
Hemab Therapeutics Holdings, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 11 in the last 12 months · 11 in all · newest Nov 4, 2026 · oldest 2026
Where Hemab Therapeutics Holdings, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:COAG · Home listing · This page | NASDAQ | United States | USD |
| BOATS:COAG | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Hemab Therapeutics Holdings, Inc.